8CT4
Cryo-EM structure of Mtb Lpd bound to inhibitor complex with 2-((2-cyano-N,5-dimethyl-1H-indole)-7-sulfonamido)-N-(4-(oxetan-3-yl)-3,4-dihydro-2H-benzo[b] [1,4]oxazin-7-yl)acetamide
Summary for 8CT4
Entry DOI | 10.2210/pdb8ct4/pdb |
Related | 7kmy |
EMDB information | 26981 |
Descriptor | Dihydrolipoyl dehydrogenase, FLAVIN-ADENINE DINUCLEOTIDE, N~2~-(2-cyano-5-methyl-1H-indole-7-sulfonyl)-N~2~-methyl-N-[4-(oxetan-3-yl)-3,4-dihydro-2H-1,4-benzoxazin-7-yl]glycinamide, ... (4 entities in total) |
Functional Keywords | flavoprotein, glycolysis, redox-active center, oxidoreductase-inhibitor complex, oxidoreductase/inhibitor |
Biological source | Mycobacterium tuberculosis |
Total number of polymer chains | 2 |
Total formula weight | 101436.27 |
Authors | Kochanczyk, T.,Arango, N.,Lima, C.D. (deposition date: 2022-05-13, release date: 2022-05-25, Last modification date: 2023-06-07) |
Primary citation | Kochanczyk, T.,Arango, N.,Michino, M.,Sun, S.,Ginn, J.,Bryk, R.,Nathan, C.,Lima, C.D. Cryo-EM structure of Mtb Lpd bound to the inhibitor 2-((2-cyano-N,5-dimethyl-1H-indole)-7-sulfonamido)-N-(4-(oxetan-3-yl)-3,4-dihydro-2H-benzo[b] [1,4]oxazin-7-yl)acetamide at 2.17 Angstrom resolution Not published, |
Experimental method | ELECTRON MICROSCOPY (2.17 Å) |
Structure validation
Download full validation report